These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9069295)

  • 1. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
    Stuschke M; Thames HD
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
    Stuschke M; Thames HD
    Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
    Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
    Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
    Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
    Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
    Overgaard J
    Radiother Oncol; 2011 Jul; 100(1):22-32. PubMed ID: 21511351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [For which tumor entities are effects of overall treatment time on the results of radiotherapy evident?].
    Stuschke M; Marnitz S; Wurm R; Budach V
    Strahlenther Onkol; 2000 Oct; 176(10):462-5. PubMed ID: 11068591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
    Horiot JC
    Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast neutron radiation therapy. Results of phase III randomized trials in head and neck, lung, and prostate cancers.
    Koh WJ; Griffin TW; Laramore GE; Stelzer KJ; Russell KJ
    Acta Oncol; 1994; 33(3):293-8. PubMed ID: 8018358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
    Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
    Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
    Kim H; Ahn YC; Park HC; Lim DH; Nam H
    J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule.
    Stuschke M; Pöttgen C
    Lung Cancer; 2004 Aug; 45 Suppl 2():S133-7. PubMed ID: 15552793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the results of neutron therapy trials.
    Duncan W
    Acta Oncol; 1994; 33(3):299-306. PubMed ID: 8018359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.